News

Temperatures are expected to skyrocket past 30C in the coming days, as the UK is on the edge of its third heatwave of the ...
The failure rate for women who used any form of birth control was 14.9 percent in 1995, meaning about 15 women out of 100 got pregnant within the first year of using birth control. But during the ...
Birth control failure rates are dropping, according to a new study released by the Guttmacher Institute. According to the study, the overall rate of failure for reversible birth control methods ...
The rocky history of Evofem and Phexxi illuminates how big insurers and drugmakers are stifling innovation in women’s health.
Failure rates for the most common forms of contraception are down, but it's not entirely clear whether it's due to education, availability, or other reasons.
Many women will also continue using birth control despite side effects because they don’t want to get pregnant – so many developers may not see improving formulations as necessary.
The Pill is the most commonly used form of birth control in the U.S. When taken exactly as directed, it’s 99.7 percent effective, making it a smart choice for many women.
The prescription will run out on your birth control and you’ll miss a couple of days, lowering your body’s guard against unwanted pregnancy. Or you’ll accidentally tear the condom putting it on.
A pharmaceutical company has recalled a birth control pill because the low level of an inactive ingredient “could potentially result in unexpected pregnancy.” Two lots of Tydemy have been ...
The upper chamber voted 51-39 to advance the Right to Contraception Act. which would have enshrined protections for Americans’ access to birth control and prohibited future bills to curb thos… ...
A team of anesthetics found that doctors fail to inform women who are undergoing surgeries about how sugammadex makes hormonal contraceptives far less effective than usual.
After years of waiting, male birth control could finally become a reality. A hormonal gel that's rubbed onto shoulders is showing success in clinical trials.